200 related articles for article (PubMed ID: 36810956)
1. Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus.
Foss-Skiftesvik J; Li S; Rosenbaum A; Hagen CM; Stoltze UK; Ljungqvist S; Hjalmars U; Schmiegelow K; Morimoto L; de Smith AJ; Mathiasen R; Metayer C; Hougaard D; Melin B; Walsh KM; Bybjerg-Grauholm J; Dahlin AM; Wiemels JL
Neuro Oncol; 2023 Sep; 25(9):1709-1720. PubMed ID: 36810956
[TBL] [Abstract][Full Text] [Related]
2. A Functional Variant on 9p21.3 Related to Glioma Risk Affects Enhancer Activity and Modulates Expression of CDKN2B-AS1.
Ali MW; Patro CPK; Devall M; Dampier CH; Plummer SJ; Kuscu C; Adli M; Lai RK; Casey G
Hum Mutat; 2021 Oct; 42(10):1208-1214. PubMed ID: 34153138
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variants in the 9p21.3 Locus Associated with Glioma Risk in Children, Adolescents, and Young Adults: A Case-Control Study.
Dahlin AM; Wibom C; Andersson U; Hougaard DM; Bybjerg-Grauholm J; Deltour I; Hultman CM; Kähler AK; Karlsson R; Hjalmars U; Melin B
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1252-1258. PubMed ID: 31040135
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma.
Atkins I; Kinnersley B; Ostrom QT; Labreche K; Il'yasova D; Armstrong GN; Eckel-Passow JE; Schoemaker MJ; Nöthen MM; Barnholtz-Sloan JS; Swerdlow AJ; Simon M; Rajaraman P; Chanock SJ; Shildkraut J; Bernstein JL; Hoffmann P; Jöckel KH; Lai RK; Claus EB; Olson SH; Johansen C; Wrensch MR; Melin B; Jenkins RB; Sanson M; Bondy ML; Houlston RS
Cancer Res; 2019 Apr; 79(8):2065-2071. PubMed ID: 30709929
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association study identifies five susceptibility loci for glioma.
Shete S; Hosking FJ; Robertson LB; Dobbins SE; Sanson M; Malmer B; Simon M; Marie Y; Boisselier B; Delattre JY; Hoang-Xuan K; El Hallani S; Idbaih A; Zelenika D; Andersson U; Henriksson R; Bergenheim AT; Feychting M; Lönn S; Ahlbom A; Schramm J; Linnebank M; Hemminki K; Kumar R; Hepworth SJ; Price A; Armstrong G; Liu Y; Gu X; Yu R; Lau C; Schoemaker M; Muir K; Swerdlow A; Lathrop M; Bondy M; Houlston RS
Nat Genet; 2009 Aug; 41(8):899-904. PubMed ID: 19578367
[TBL] [Abstract][Full Text] [Related]
6. Common variants in CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma identified by genome-wide association studies in Japanese.
Nakano M; Ikeda Y; Tokuda Y; Fuwa M; Omi N; Ueno M; Imai K; Adachi H; Kageyama M; Mori K; Kinoshita S; Tashiro K
PLoS One; 2012; 7(3):e33389. PubMed ID: 22428042
[TBL] [Abstract][Full Text] [Related]
7. Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
Dahlin AM; Wibom C; Ghasimi S; Brännström T; Andersson U; Melin B
PLoS One; 2016; 11(10):e0163067. PubMed ID: 27780202
[TBL] [Abstract][Full Text] [Related]
8. Association of a Chromosome Locus 9p21.3 CDKN2B-AS1 Variant rs4977574 with Hypertension: The TAMRISK Study.
Kunnas T; Piesanen J; Nikkari ST
Genet Test Mol Biomarkers; 2018 May; 22(5):327-330. PubMed ID: 29791233
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locus.
Antikainen AAV; Sandholm N; Trégouët DA; Charmet R; McKnight AJ; Ahluwalia TS; Syreeni A; Valo E; Forsblom C; Gordin D; Harjutsalo V; Hadjadj S; Maxwell AP; Rossing P; Groop PH
Cardiovasc Res; 2021 Jan; 117(2):600-612. PubMed ID: 32077919
[TBL] [Abstract][Full Text] [Related]
10. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
Wrensch M; Jenkins RB; Chang JS; Yeh RF; Xiao Y; Decker PA; Ballman KV; Berger M; Buckner JC; Chang S; Giannini C; Halder C; Kollmeyer TM; Kosel ML; LaChance DH; McCoy L; O'Neill BP; Patoka J; Pico AR; Prados M; Quesenberry C; Rice T; Rynearson AL; Smirnov I; Tihan T; Wiemels J; Yang P; Wiencke JK
Nat Genet; 2009 Aug; 41(8):905-8. PubMed ID: 19578366
[TBL] [Abstract][Full Text] [Related]
11. Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis.
Thakur N; Kupani M; Mannan R; Pruthi A; Mehrotra S
BMC Med Genomics; 2021 Jan; 14(1):1. PubMed ID: 33397358
[TBL] [Abstract][Full Text] [Related]
12. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.
Alpen K; Vajdic CM; MacInnis RJ; Milne RL; Koh ES; Hovey E; Harrup R; Bruinsma F; Nguyen TL; Li S; Joseph D; Benke G; Dugué PA; Southey MC; Giles GG; Rosenthal M; Drummond KJ; Nowak AK; Hopper JL; Kapuscinski M; Makalic E
Neuro Oncol; 2023 Jul; 25(7):1355-1365. PubMed ID: 36541697
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers.
Li WQ; Pfeiffer RM; Hyland PL; Shi J; Gu F; Wang Z; Bhattacharjee S; Luo J; Xiong X; Yeager M; Deng X; Hu N; Taylor PR; Albanes D; Caporaso NE; Gapstur SM; Amundadottir L; Chanock SJ; Chatterjee N; Landi MT; Tucker MA; Goldstein AM; Yang XR
Carcinogenesis; 2014 Dec; 35(12):2698-705. PubMed ID: 25239644
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome-wide Mendelian randomization study prioritising novel tissue-dependent genes for glioma susceptibility.
Robinson JW; Martin RM; Tsavachidis S; Howell AE; Relton CL; Armstrong GN; Bondy M; Zheng J; Kurian KM
Sci Rep; 2021 Jan; 11(1):2329. PubMed ID: 33504897
[TBL] [Abstract][Full Text] [Related]
15. Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
Egan KM; Thompson RC; Nabors LB; Olson JJ; Brat DJ; Larocca RV; Brem S; Moots PL; Madden MH; Browning JE; Ann Chen Y
J Neurooncol; 2011 Sep; 104(2):535-42. PubMed ID: 21203894
[TBL] [Abstract][Full Text] [Related]
16. Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk.
Giaccherini M; Farinella R; Gentiluomo M; Mohelnikova-Duchonova B; Kauffmann EF; Palmeri M; Uzunoglu F; Soucek P; Petrauskas D; Cavestro GM; Zykus R; Carrara S; Pezzilli R; Puzzono M; Szentesi A; Neoptolemos J; Archibugi L; Palmieri O; Milanetto AC; Capurso G; van Eijck CHJ; Stocker H; Lawlor RT; Vodicka P; Lovecek M; Izbicki JR; Perri F; Kupcinskaite-Noreikiene R; Götz M; Kupcinskas J; Hussein T; Hegyi P; Busch OR; Hackert T; Mambrini A; Brenner H; Lucchesi M; Basso D; Tavano F; Schöttker B; Vanella G; Bunduc S; Petrányi Á; Landi S; Morelli L; Canzian F; Campa D
Int J Cancer; 2023 Jul; 153(2):373-379. PubMed ID: 36451333
[TBL] [Abstract][Full Text] [Related]
17. New insights into susceptibility to glioma.
Liu Y; Shete S; Hosking FJ; Robertson LB; Bondy ML; Houlston RS
Arch Neurol; 2010 Mar; 67(3):275-8. PubMed ID: 20212223
[TBL] [Abstract][Full Text] [Related]
18. Fine mapping analysis of a region of 20q13.33 identified five independent susceptibility loci for glioma in a Chinese Han population.
Song X; Zhou K; Zhao Y; Huai C; Zhao Y; Yu H; Chen Y; Chen G; Chen H; Fan W; Mao Y; Lu D
Carcinogenesis; 2012 May; 33(5):1065-71. PubMed ID: 22387365
[TBL] [Abstract][Full Text] [Related]
19. Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study.
Wibom C; Späth F; Dahlin AM; Langseth H; Hovig E; Rajaraman P; Johannesen TB; Andersson U; Melin B
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):810-6. PubMed ID: 25713050
[TBL] [Abstract][Full Text] [Related]
20. CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.
Adel Fahmideh M; Lavebratt C; Schüz J; Röösli M; Tynes T; Grotzer MA; Johansen C; Kuehni CE; Lannering B; Prochazka M; Schmidt LS; Feychting M
Carcinogenesis; 2015 Aug; 36(8):876-82. PubMed ID: 26014354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
